Fairvoy Private Wealth’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
SP
CRM
SW
AWA
SFA
Fairvoy Private Wealth's AMGN Position: Q2 2026 in Review
Fairvoy Private Wealth reduced its Amgen (AMGN) stake by 0.46% in Q2 2026, selling an estimated $5.13K and leaving 3,257 shares worth $1.18M. The position accounts for 0.24% of the portfolio, ranked #93.
Fairvoy Private Wealth first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 748 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Fairvoy Private Wealth held 3,257 shares of Amgen worth $1.18M as of Q2 2026.
- Fairvoy Private Wealth sold 15 Amgen shares in Q2 2026, an estimated $5.13K.
- Amgen made up 0.24% of Fairvoy Private Wealth's portfolio in Q2 2026, its #93 holding.
- Fairvoy Private Wealth first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
- 748 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Fairvoy Private Wealth's 13F filing for Q2 2026, filed 17 Jul 2026.